Nobilis Rismavac

Nobilis Rismavac consists of a suspension of living cultured avian cells containing at least 3.0 log_{10 TCID50 of attenuated Marek's Disease virus (strain CVI 998) per dose. The vaccine contains stabilisers and antibiotics at a maximum concentration of 40 µg/ml neomycin, 40 µg/ml polymyxin and 2.5 µg/ml amphotericin B.}

_{The vaccine is supplied in frozen ampoules held in metal canes stored in a liquid nitrogen canister. Diluent Cell Associated Marek vaccine is supplied for reconstitution of the vaccine prior to use.}

Legal Statement:  PML

Nobilis Rismavaccontains ofa suspension of living cultured avian cells containing at least 3.0 log10 TCID50 of attenuated Marek's Disease virus (strain CVI 998) per dose. The vaccine contains stabilisers and antibiotics at a maximum concentration of 40 µg/ml neomycin, 40 µg/ml polymyxin and 2.5 µg/ml amphotericin B.

The vaccine is supplied in frozen ampoules held in metal canes stored in a liquid nitrogen canister. Diluent Cell Associated Marek vaccine is supplied for reconstitution of the vaccine prior to use. For uses, dosage. contra-indications and warnings, see datasheet. Further information is available on request.